Jay Moyes, a director at Puma Biotechnology, has executed a sale of company stock valued at $158,000. This transaction is part of Moyes' ongoing management of his investment portfolio. The sale reflects standard practices among corporate executives regarding stock ownership and liquidity. Details regarding the specific number of shares sold or the timing of the transaction have not been disclosed.
Related Articles
Don't miss out on breaking stories and in-depth articles.